By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Investigators discuss new findings in Immune System Diseases and Conditions - HIV/AIDS. According to news reporting out of Washington, District of Columbia, by NewsRx editors, research stated, “The new World Health Organization and Joint United Nations Programme on HIV/AIDS strategic framework for voluntary medical male circumcision (VMMC) aims to increase VMMC coverage among males aged 10-29 years in priority settings to 90% by 2021. We use mathematical modeling to assess the likelihood that selected countries will achieve this objective, given their historical VMMC progress and current implementation options.”

Our news journalists obtained a quote from the research from US Agency for International Development, “We use the Decision Makers’ Program Planning Toolkit, version 2, to examine 4 ambitious but feasible scenarios for scaling up VMMC coverage from 2017 through 2021, inclusive in Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Tanzania, Uganda, and Zimbabwe. Tanzania is the only country that would reach the goal of 90% VMMC coverage in 10- to 29-year-olds by the end of 2021 in the scenarios assessed, and this was true in 3 of the scenarios studied. Mozambique, South Africa, and Lesotho would come close to reaching the objective only in the most ambitious scenario examined. Major changes in VMMC implementation in most countries will be required to increase the proportion of circumcised 10- to 29-year-olds to 90% by the end of 2021.”

According to the news editors, the research concluded: “Scaling up VMMC coverage in males aged 10-29 years will require significantly increasing the number of circumcisions provided to 10- to 14-year-olds and 15- to 29-year-olds.”

For more information on this research see: Scaling Up Voluntary Medical Male Circumcision for Human Immunodeficiency Virus Prevention for Adolescents and Young Adult Men: A Modeling Analysis of Implementation and Impact in Selected Countries. Clinical Infectious Diseases , 2018;66():S166-S172. Clinical Infectious Diseases can be contacted at: Oxford Univ Press Inc, Journals Dept, 2001 Evans Rd, Cary, NC 27513, USA. (Oxford University Press - http://www.oup.com/; Clinical Infectious Diseases - cid.oxfordjournals.org)

Our news journalists report that additional information may be obtained by contacting E. Njeuhmeli, US Agcy Int Dev, Off HIV AIDS, Global Hlth Bur, Washington, DC 20523, United States. Additional authors for this research include M. Opuni, M. Schnure, M. Tchuenche, P. Stegman, E. Gold, V. Kiggundu, N. Parks, K.S. Ahanda, M. Carrasco and K. Kripke.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1093/cid/cix969. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

CITATION: (2018-05-06), Research Conducted at US Agency for International Development Has Updated Our Knowledge about HIV/AIDS (Scaling Up Voluntary Medical Male Circumcision for Human Immunodeficiency Virus Prevention for Adolescents and Young Adult Men: A Modeling ...), Medical Devices & Surgical Technology Week, 830, ISSN: 1537-1417, BUTTER® ID: 015572247

From the newsletter Medical Devices & Surgical Technology Week.
https://www.newsrx.com/Butter/#!Search:a=15572247

This is a NewsRx^® article created by NewsRx^® and posted by NewsRx^®. As proof that we are NewsRx^® posting NewsRx^® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.

We have been in business for more than 20 years and our full contact information is available on our main corporate website.

We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.

NewsRx^® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.

View Newsletter Titles

About NewsRx^® and Contact Information

Topics